Distributable cash flow remains highly unstable, as evidenced by the 2025Q4 period where maintenance capital expenditures of $11.8 million exceeded the $10.0 million in reported operating cash flow.
| Cash from Operations | 37.19M | 6.95M | -79.85M | 21.62M | 28.3M | 38.88M | 41.81M | 47.4M |
| Operating CF Growth % | 333.41% | 108.71% | -469.25% | -23.58% | -27.22% | -7% | -11.81% | - |
| Operating CF / Revenue % | 10.87% | 2.03% | -22.57% | 6.25% | 8.42% | 11.8% | 10.96% | 12.64% |
| Net Income | -60.36M | -57.69M | -190.26M | -72.38M | -79.62M | -85.44M | -75.51M | -88.31M |
| Depreciation & Amortization | 69.96M | 78.26M | 82.64M | 81.98M | 81.44M | 79.73M | 80.97M | 81.03M |
| Stock-Based Compensation | 4.38M | 3.77M | 613K | 919K | 1.19M | 1.33M | 1.34M | 1.32M |
| Other Non-Cash Items | 37.52M | 26.52M | 24.21M | 16.4M | 32.72M | 43.69M | 38.99M | 62.72M |
| Working Capital Changes | -15.24M | -45.62M | 558K | -6.46M | -10.18M | 57K | -8.63M | -9.36M |
| Cash from Investing | -13.66M | 69.81M | 63.97M | -62.82M | -41.78M | -47.92M | -82.49M | -46.25M |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -1.53M | -1.38M | -1.71M | -9.96M | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 16.2M | 99.91M | 87.59M | -30.46M | -13.79M | -28.85M | -60.6M | -29.53M |
| Cash from Financing | -43.35M | -42.4M | -1.35M | 55.97M | 4.64M | 4.08M | 19.43M | 19.09M |
| Dividends Paid | -13.29M | -13.45M | -13.8M | -13.8M | -13.8M | -5.14M | -33.75M | -51.43M |
| Common Dividends | 0 | 0 | 0 | 0 | 0 | 0 | -31.35M | -51.43M |
| Debt Issuance (Net) | -2M | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K |
| Share Repurchases | -920K | -5.42M | 0 | 0 | -42K | 0 | -11.55M | -21.11M |
| Other Financing | -2.85M | 4.48M | -184K | -8.65M | -1.86M | -1.62M | -3.12M | -22.02M |
| Net Change in Cash | -19.81M | 34.36M | -17.22M | 14.78M | -8.84M | -4.96M | -21.25M | 20.24M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 108.45M | 74.09M | 91.32M | 76.54M | 85.38M | 90.35M | 111.6M | 91.36M |
| Cash at End | 106.6M | 108.45M | 74.09M | 91.32M | 76.54M | 85.38M | 90.35M | 111.6M |
| Free Cash Flow | 8.87M | -21.77M | -101.75M | -773K | 302K | 19.81M | 19.91M | 30.68M |
| FCF Growth % | 107.04% | 78.6% | -13063.52% | -355.96% | -98.48% | -0.54% | -35.1% | - |
| FCF / Revenue % | 2.59% | -6.36% | -28.76% | -0.22% | 0.09% | 6.01% | 5.22% | 8.18% |
Persistent Negative Net Income
As reported in quarterly financial statements, NHPBP's AFFO has frequently failed to cover dividend payments, with multiple periods showing negative distributable cash flow, such as the -$16.5 million recorded in 2025Q4, which suggests a structural inability to sustain distributions from recurring property-level cash generation.
The inconsistency in AFFO generation indicates that the dividend is not supported by core operational performance. Investors should monitor the frequent gaps in coverage, which imply that distributions may be funded through non-recurring sources or capital recycling rather than sustainable property income.
Based on the provided cash flow data, recurring capital expenditures, including tenant improvements and maintenance, consistently offset a significant portion of operating cash flow, with 2025Q4 maintenance spending of $11.8 million exceeding the $10.0 million in reported operating cash flow for that same period.
This high level of capital intensity relative to cash flow suggests that the portfolio requires constant reinvestment to maintain occupancy, further pressuring the net cash available for shareholders. The persistent drain from these expenditures appears to be a primary factor in the company's inability to generate positive free cash flow on a consistent basis.
According to historical filings, the wide divergence between GAAP net income and FFO, exemplified by the 2024Q2 net loss of $116.5 million versus an FFO loss of $94.1 million, highlights how heavy non-cash depreciation charges obscure the actual cash-generating capacity of the firm's healthcare assets.
While FFO is intended to normalize these distortions, the volatility in the FFO metric itself suggests that the underlying operations are subject to significant swings that GAAP accounting fails to capture. This disconnect warrants further investigation into whether the company's asset base is truly generating the cash flow required to support its capital structure.
As indicated by the provided data, the conversion of GAAP operating cash flow into FFO is highly erratic, with the FFO/NI ratio reaching an extreme 13.53 in 2025Q1, suggesting that the company's reported earnings are not a reliable proxy for its actual cash-based performance.
The lack of a stable relationship between operating cash flow and FFO suggests that working capital fluctuations and non-recurring items are significantly impacting the company's reported figures. This volatility makes it difficult to project future cash availability and suggests that the company's cash flow quality is currently weak.
Quick answers to the most common questions about buying NHPBP stock.
National Healthcare Properties, Inc. (NHPBP) generated $7.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
National Healthcare Properties, Inc. (NHPBP) reported negative free cash flow of $21.8M in 2025, indicating capital requirements exceeded cash from operations.
National Healthcare Properties, Inc. (NHPBP) spent $28.7M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, National Healthcare Properties, Inc. (NHPBP) returned $13.4M to shareholders via cash dividends and spent $5.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.